CHAQ.WS (Chardan Healthcare Acquisition 2) ROE % : -0.61% (As of Jun. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Chardan Healthcare Acquisition 2 ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Chardan Healthcare Acquisition 2's annualized net income for the quarter that ended in Jun. 2021 was $-0.49 Mil. Chardan Healthcare Acquisition 2's average Total Stockholders Equity over the quarter that ended in Jun. 2021 was $80.64 Mil. Therefore, Chardan Healthcare Acquisition 2's annualized ROE % for the quarter that ended in Jun. 2021 was -0.61%.

The historical rank and industry rank for Chardan Healthcare Acquisition 2's ROE % or its related term are showing as below:

CHAQ.WS' s ROE % Range Over the Past 10 Years
Min: -9.52 Med: -5.67 Max: -1.81
Current: -2.83

During the past 3 years, Chardan Healthcare Acquisition 2's highest ROE % was -1.81%. The lowest was -9.52%. And the median was -5.67%.

CHAQ.WS's ROE % is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.64 vs CHAQ.WS: -2.83

Chardan Healthcare Acquisition 2 ROE % Historical Data

The historical data trend for Chardan Healthcare Acquisition 2's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chardan Healthcare Acquisition 2 ROE % Chart

Chardan Healthcare Acquisition 2 Annual Data

Trend

Dec18

Dec19

Dec20

ROE %

-9.52

-1.81

Chardan Healthcare Acquisition 2 Semi-Annual Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
ROE %	Get a 7-Day Free Trial			-4.14	-0.56	-0.24	-1.43	-0.61

Competitive Comparison of Chardan Healthcare Acquisition 2's ROE %

For the Shell Companies subindustry, Chardan Healthcare Acquisition 2's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chardan Healthcare Acquisition 2's ROE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Chardan Healthcare Acquisition 2's ROE % distribution charts can be found below:

* The bar in red indicates where Chardan Healthcare Acquisition 2's ROE % falls into.

Chardan Healthcare Acquisition 2 ROE % Calculation

Chardan Healthcare Acquisition 2's annualized ROE % for the fiscal year that ended in Dec. 2020 is calculated as

ROE %	=	Net Income (A: Dec. 2020 )	/	( (Total Stockholders Equity (A: Dec. 2019 )	+	Total Stockholders Equity (A: Dec. 2020 ))	/ count )
	=	-0.781	/	( (0.023	+	86.106)	/ 2 )
	=	-0.781	/	43.0645
	=	-1.81 %

Chardan Healthcare Acquisition 2's annualized ROE % for the quarter that ended in Jun. 2021 is calculated as

ROE %	=	Net Income (Q: Jun. 2021 )	/	( (Total Stockholders Equity (Q: Mar. 2021 )	+	Total Stockholders Equity (Q: Jun. 2021 ))	/ count )
	=	-0.488	/	( (80.884	+	80.396)	/ 2 )
	=	-0.488	/	80.64
	=	-0.61 %

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Jun. 2021) net income data. ROE % is displayed in the 30-year financial page.

Chardan Healthcare Acquisition 2 (AMEX:CHAQ.WS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

	ROE %		(Q: Jun. 2021 )
=	Net Income	/	Total Stockholders Equity
=	-0.488	/	80.64
=	(Net Income / Revenue )	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-0.488 / 0)	*	(0 / 86.7065)	*	(86.7065 / 80.64)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	N/A %	*	0	*	1.0752
=	ROA %	*	Equity Multiplier
=	N/A %	*	1.0752
=	-0.61 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

	ROE %		(Q: Jun. 2021 )
=	Net Income	/	Total Stockholders Equity
=	-0.488	/	80.64
=	(Net Income / Pre-Tax Income)	*	(Pre-Tax Income / Operating Income)	*	(Operating Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-0.488 / -0.488)	*	(-0.488 / -1.086)	*	(-1.086 / 0)	*	(0 / 86.7065)	*	(86.7065 / 80.64)
=	Tax Burden	*	Interest Burden	*	Operating Margin %	*	Asset Turnover	*	Equity Multiplier
=	1	*	0.4494	*	N/A %	*	0	*	1.0752
=	-0.61 %

Note: The net income data used here is one times the annual (Jun. 2021) net income data. The Revenue data used here is one times the annual (Jun. 2021) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
^* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

Chardan Healthcare Acquisition 2 ROE % Related Terms

Thank you for viewing the detailed overview of Chardan Healthcare Acquisition 2's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chardan Healthcare Acquisition 2 Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Chardan Healthcare Acquisition 2 Corp (AMEX:CHAQ.WS) » Definitions » ROE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 State Street, 21st Floor, New York, NY, USA, 10004

Website

https://www.chardanhealthcarespac.com

Chardan Healthcare Acquisition 2 Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination.